Improving Solid Dosage Forms With Dry Granulation - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Improving Solid Dosage Forms With Dry Granulation
Although tablet manufacture is traditionally a batchbased wet granulation process, there are many advantages to be gained by adopting dry granulation, including lower costs and increased yields. The simplicity of dry granulation could also enable it to become one of the main technologies for continuous processing.


Pharmaceutical Technology Europe
Volume 23, Issue 3



The pharma industry traditionally utilises batchbased manufacturing methods because of traceability requirements to ensure product safety. After several years of establishing new ways of analysing drug variability and quality in various manufacturing process stages (under the PAT initiative), the industry is moving away from conventional batch sampling and analysis to embrace more advanced techniques that analyse consistency in real time. The challenge now is for the industry to take this QbD concept and look at its manufacturing processes in lean terms to adapt for a more efficient future.

Continuous granulation processes


Sidebar 1: Key advances made by new roller compaction systems
Tablet manufacture is traditionally a batch-based wet granulation process. Dry granulation, on the other hand, can be used as a semibatch process but could also emerge as one of the main continuous processing solutions due to its simplicity. There are other forms of dry granulation, but the most commonly used is roller compaction, which is a continuous technology by design that has been significantly further developed in recent years. In particular, a number of important changes have been made that differentiate novel technologies from conventional roller compactors (Sidebar 1).

Combined with PAT techniques, roller compaction can help achieve a continuous granulation process. Depending on the objectives and site PAT strategy, measurements prior to the process can be taken to establish raw material consistency and blend uniformity. Essentially, this will enable a consistent processing window with established boundary limits to be achieved.


Sidebar 2: Terahertz pulsed imaging of pharmaceutical compacts
Sidebar 2 provides an example of PAT analysis data based on the measurement of terahertz wave forms, which are reflected from pharmaceutical roller compactions of various densities. The example demonstrates the potential for the technique as an in-line technology to analyse critical material attributes of compacted ribbons prior to milling to establish increased process understanding.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology Europe,
Click here